Prevention and Treatment of HIV and STIs in 2024: Where Are We Now?
As we advance through 2024, significant updates in Human Immunodeficiency Virus (HIV) and Sexually Transmitted Infections (STI) prevention and treatment are emerging. Recent clinical trials and global research highlight both advances and ongoing challenges in these critical public health areas. How will these developments influence current practices and shape future strategies in HIV and STI management?
In this webinar, our expert speaker will explore these updates, presenting recent epidemiological data on HIV and STIs worldwide to provide a clear picture of current trends. You’ll gain insights into the latest advancements in HIV treatment and prevention, including innovations in long-acting formulations. The session will also cover recent progress in STI treatment and prevention, focusing on emerging strategies such as the use of doxycycline as postexposure prophylaxis.
In this webinar, our expert speaker will:
- Present recent epidemiology of HIV and STIs globally
- Provide updates on HIV and STI treatment and prevention, including doxycycline as postexposure prophylaxis and long-acting formulations
- Review recent clinical trial and implementation data from global research efforts
Speaker
Dr. Meredith Clement
Associate Professor
Louisiana State University Health Sciences Center
Brought to you by
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version
